{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:22Z","timestamp":1772165602783,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["CA179115"],"award-info":[{"award-number":["CA179115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["CA179115"],"award-info":[{"award-number":["CA179115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["CA179115"],"award-info":[{"award-number":["CA179115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["CA179115"],"award-info":[{"award-number":["CA179115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["CA179115"],"award-info":[{"award-number":["CA179115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["P30 CA054174"],"award-info":[{"award-number":["P30 CA054174"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["CA179115"],"award-info":[{"award-number":["CA179115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["CA179115"],"award-info":[{"award-number":["CA179115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["CA179115"],"award-info":[{"award-number":["CA179115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["CA179115"],"award-info":[{"award-number":["CA179115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["CA179115"],"award-info":[{"award-number":["CA179115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["CA179115"],"award-info":[{"award-number":["CA179115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We compared six commonly used logistic regression methods for accommodating missing risk factor data from multiple heterogeneous cohorts, in which some cohorts do not collect some risk factors at all, and developed an online risk prediction tool that accommodates missing risk factors from the end-user.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ten North American and European cohorts from the Prostate Biopsy Collaborative Group (PBCG) were used for fitting a risk prediction tool for clinically significant prostate cancer, defined as Gleason grade group\u2009\u2265\u20092 on standard TRUS prostate biopsy. One large European PBCG cohort was withheld for external validation, where calibration-in-the-large (CIL), calibration curves, and area-underneath-the-receiver-operating characteristic curve (AUC) were evaluated. Ten-fold leave-one-cohort-internal validation further validated the optimal missing data approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 12,703 biopsies from 10 training cohorts, 3,597 (28%) had clinically significant prostate cancer, compared to 1,757 of 5,540 (32%) in the external validation cohort. In external validation, the available cases method that pooled individual patient data containing all risk factors input by an end-user had best CIL, under-predicting risks as percentages by 2.9% on average, and obtained an AUC of 75.7%. Imputation had the worst CIL (-13.3%). The available cases method was further validated as optimal in internal cross-validation and thus used for development of an online risk tool. For end-users of the risk tool, two risk factors were mandatory: serum prostate-specific antigen (PSA) and age, and ten were optional: digital rectal exam, prostate volume, prior negative biopsy, 5-alpha-reductase-inhibitor use, prior PSA screen, African ancestry, Hispanic ethnicity, first-degree prostate-, breast-, and second-degree prostate-cancer family history.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Developers of clinical risk prediction tools should optimize use of available data and sources even in the presence of high amounts of missing data and offer options for users with missing risk factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12874-022-01674-x","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T09:03:34Z","timestamp":1658394214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Accommodating heterogeneous missing data patterns for prostate cancer risk prediction"],"prefix":"10.1186","volume":"22","author":[{"given":"Matthias","family":"Neumair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Kattan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Haese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Guerrios-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"De Hoedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Liss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin J.","family":"Leach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Cooperberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cedric","family":"Poyet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Saba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Herkommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin H.","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna P.","family":"Ankerst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,21]]},"reference":[{"issue":"17","key":"1674_CR1","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1158\/1078-0432.CCR-10-1328","volume":"16","author":"AJ Vickers","year":"2010","unstructured":"Vickers AJ, Cronin AM, Roobol MJ, Hugosson J, Jones JS, Kattan MW, et al. The relationship between prostate-specific antigen and prostate cancer risk: the prostate biopsy collaborative group. Clin Cancer Res. 2010;16(17):4374\u201381. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1328.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1674_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.eururo.2018.05.003","volume":"74","author":"DP Ankerst","year":"2018","unstructured":"Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, et al. A contemporary prostate biopsy risk calculator based on multiple heterogeneous cohorts. Eur Urol. 2018;74(2):197\u2013203. https:\/\/doi.org\/10.1016\/j.eururo.2018.05.003.","journal-title":"Eur Urol"},{"issue":"1","key":"1674_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12874-019-0839-0","volume":"19","author":"J Tolksdorf","year":"2019","unstructured":"Tolksdorf J, Kattan MW, Boorjian SA, Freedland SJ, Saba K, Poyet C, et al. Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools. BMC Med Res Methodol. 2019;19(1):191. https:\/\/doi.org\/10.1186\/s12874-019-0839-0.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"1674_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12911-020-01174-2","volume":"20","author":"A Jalali","year":"2020","unstructured":"Jalali A, Foley RW, Maweni RM, Murphy K, Lundon DJ, Lynch T, et al. A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort. BMC Med Inform Decis Mak. 2020;20(1):148. https:\/\/doi.org\/10.1186\/s12911-020-01174-2.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"10","key":"1674_CR5","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s11255-020-02517-8","volume":"52","author":"M Stojadinovic","year":"2020","unstructured":"Stojadinovic M, Trifunovic T, Jankovic S. Adaptation of the prostate biopsy collaborative group risk calculator in patients with PSA less than 10 ng\/ml improves its performance. Int Urol Nephrol. 2020;52(10):1811\u20139. https:\/\/doi.org\/10.1007\/s11255-020-02517-8.","journal-title":"Int Urol Nephrol"},{"issue":"20","key":"1674_CR6","doi-asserted-by":"publisher","first-page":"30113","DOI":"10.1016\/j.euf.2020.05.002","volume":"S2405\u20134569","author":"A Mortezavi","year":"2020","unstructured":"Mortezavi A, Palsdottir T, Eklund M, Chellappa V, Murugan SK, Saba K, et al. Head-to-head comparison of conventional, and image- and biomarker-based prostate cancer risk calculators. Eur Urol Focus. 2020;S2405\u20134569(20):30113\u20139. https:\/\/doi.org\/10.1016\/j.euf.2020.05.002.","journal-title":"Eur Urol Focus"},{"issue":"6","key":"1674_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/pros.23964","volume":"80","author":"J Rubio-Briones","year":"2020","unstructured":"Rubio-Briones J, Borque-Fernando A, Esteban LM, Mascar\u00f3s JM, Ram\u00edrez-Backhaus M, Casanova J, et al. Validation of a 2-gene mRNA urine test for the detection of \u2265GG2 prostate cancer in an opportunistic screening population. Prostate. 2020;80(6):500\u20137. https:\/\/doi.org\/10.1002\/pros.23964.","journal-title":"Prostate"},{"issue":"1","key":"1674_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12894-019-0553-6","volume":"19","author":"S Carbunaru","year":"2019","unstructured":"Carbunaru S, Nettey OS, Gogana P, Helenowski IB, Jovanovic B, Ruden M, et al. A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort. BMC Urol. 2019;19(1):121. https:\/\/doi.org\/10.1186\/s12894-019-0553-6.","journal-title":"BMC Urol."},{"issue":"7","key":"1674_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jclinepi.2009.12.008","volume":"63","author":"KJ Janssen","year":"2010","unstructured":"Janssen KJ, Donders AR, Harrell FE Jr, Vergouwe Y, Chen Q, Grobbee DE, Moons KG. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol. 2010;63(7):721\u20137. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.12.008.","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"1674_CR10","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","volume":"59","author":"AR Donders","year":"2006","unstructured":"Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59(10):1087\u201391. https:\/\/doi.org\/10.1016\/j.jclinepi.2006.01.014.","journal-title":"J Clin Epidemiol"},{"issue":"134","key":"1674_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jclinepi.2021.01.003","volume":"19","author":"SWJ Nijman","year":"2021","unstructured":"Nijman SWJ, Groenhof TKJ, Hoogland J, Bots ML, Brandjes M, Jacobs JJL, et al. Real-time imputation of missing predictor values improved the application of prediction models in daily practice. J Clin Epidemiol. 2021;19(134):22\u201334. https:\/\/doi.org\/10.1016\/j.jclinepi.2021.01.003.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"1674_CR12","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.urology.2014.02.035","volume":"83","author":"DP Ankerst","year":"2014","unstructured":"Ankerst DP, Hoefler J, Bock S, Goodman PJ, Vickers A, Hernandez J, et al. Prostate cancer prevention trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. Urology. 2014;83(6):1362\u20137. https:\/\/doi.org\/10.1016\/j.urology.2014.02.035.","journal-title":"Urology"},{"issue":"1","key":"1674_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.eururo.2018.07.021","volume":"75","author":"AG Zhou","year":"2019","unstructured":"Zhou AG, Salles DC, Samarska IV, Epstein JI. How are gleason scores categorized in the current literature: an analysis and comparison of articles published in 2016\u20132017. Eur Urol. 2019;75(1):25\u201331. https:\/\/doi.org\/10.1016\/j.eururo.2018.07.021.","journal-title":"Eur Urol"},{"issue":"3","key":"1674_CR14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.eururo.2011.11.012","volume":"61","author":"MJ Roobol","year":"2012","unstructured":"Roobol MJ, van Vugt HA, Loeb S, Zhu X, Bul M, Bangma CH, van Leenders AG, Steyerberg EW, Schr\u00f6der FH. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators. Eur Urol. 2012;61(3):577\u201383. https:\/\/doi.org\/10.1016\/j.eururo.2011.11.012.","journal-title":"Eur Urol"},{"issue":"11","key":"1674_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1503\/cmaj.110977","volume":"184","author":"RH Groenwold","year":"2012","unstructured":"Groenwold RH, White IR, Donders AR, Carpenter JR, Altman DG, Moons KG. Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis. CMAJ. 2012;184(11):1265\u20139. https:\/\/doi.org\/10.1503\/cmaj.110977.","journal-title":"CMAJ"},{"issue":"3","key":"1674_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S Van Buuren","year":"2011","unstructured":"Van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1\u201367. https:\/\/doi.org\/10.18637\/jss.v045.i03.","journal-title":"J Stat Softw"},{"issue":"4","key":"1674_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377\u201399. https:\/\/doi.org\/10.1002\/sim.4067.","journal-title":"Stat Med"},{"key":"1674_CR18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/10705510802339072","volume":"15","author":"TE Bodner","year":"2008","unstructured":"Bodner TE. What improves with increased missing data imputations? Psychology Press. 2008;15:651\u201375. https:\/\/doi.org\/10.1080\/10705510802339072.","journal-title":"Psychology Press"},{"key":"1674_CR19","volume-title":"A language and environment for statistical computing. R Foundation for statistical computing, Vienna, Austria","author":"R Core Team R","year":"2020","unstructured":"R Core Team R. A language and environment for statistical computing. R Foundation for statistical computing, Vienna, Austria. 2020. Available from: https:\/\/www.R-project.org\/."},{"issue":"4","key":"1674_CR20","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/biomet\/asv035","volume":"102","author":"F Mealli","year":"2015","unstructured":"Mealli F, Rubin DB. Clarifying missing at random and related definitions, and implications when coupled with exchangeability. Biometrika. 2015;102(4):995\u20131000. https:\/\/doi.org\/10.1093\/biomet\/asv035.","journal-title":"Biometrika"},{"key":"1674_CR21","doi-asserted-by":"publisher","first-page":"175628722210885","DOI":"10.1177\/17562872221088536","volume":"14","author":"LAMJG van Riel","year":"2022","unstructured":"van Riel LAMJG, Jager A, Meijer D, Postema AW, Smit RS, Vis AN, et al. Predictors of clinically significant prostate cancer in biopsy-na\u00efve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator. Ther Adv Urol. 2022;14:17562872221088536. https:\/\/doi.org\/10.1177\/17562872221088536.","journal-title":"Ther Adv Urol"},{"issue":"2","key":"1674_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/and.14329","volume":"54","author":"M Y\u0131ld\u0131zhan","year":"2022","unstructured":"Y\u0131ld\u0131zhan M, Balc\u0131 M, Ero\u011flu U, Asil E, Coser S, \u00d6zercan AY, et al. An analysis of three different prostate cancer risk calculators applied prior to prostate biopsy: a Turkish cohort validation study. Andrologia. 2022;54(2): e14329. https:\/\/doi.org\/10.1111\/and.14329.","journal-title":"Andrologia"},{"issue":"Suppl 3","key":"1674_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/bju.15554","volume":"128","author":"P Doan","year":"2021","unstructured":"Doan P, Graham P, Lahoud J, Remmers S, Roobol MJ, Kim L, Patel MI. A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant? BJU Int. 2021;128(Suppl 3):36\u201344. https:\/\/doi.org\/10.1111\/bju.15554.","journal-title":"BJU Int"},{"issue":"12","key":"1674_CR24","doi-asserted-by":"publisher","first-page":"831.e11","DOI":"10.1016\/j.urolonc.2021.05.022","volume":"39","author":"E Amaya-Fragoso","year":"2021","unstructured":"Amaya-Fragoso E, Garc\u00eda-P\u00e9rez CM. Improving prostate biopsy decision making in Mexican patients: Still a major public health concern. Urol Oncol. 2021;39(12):831.e11-831.e18. https:\/\/doi.org\/10.1016\/j.urolonc.2021.05.022.","journal-title":"Urol Oncol"},{"issue":"11","key":"1674_CR25","doi-asserted-by":"publisher","first-page":"783.e11","DOI":"10.1016\/j.urolonc.2021.03.023","volume":"39","author":"JC Presti","year":"2021","unstructured":"Presti JC, Alexeeff S, Horton B, Prausnitz S, Avins AL. Prospective validation of the Kaiser permanente prostate cancer risk calculator in a contemporary, racially diverse, referral population. Urol Oncol. 2021;39(11):783.e11-783.e19. https:\/\/doi.org\/10.1016\/j.urolonc.2021.03.023.","journal-title":"Urol Oncol"},{"issue":"1","key":"1674_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12894-019-0553-6","volume":"19","author":"S Carbunaru S","year":"2019","unstructured":"Carbunaru S S, Nettey OS OS, Gogana P, Helenowski IB, Jovanovic B, Ruden M, et al. A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort. BMC Urol. 2019;19(1):121. https:\/\/doi.org\/10.1186\/s12894-019-0553-6.","journal-title":"BMC Urol"},{"issue":"4","key":"1674_CR27","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/ije\/dyz032","volume":"48","author":"RA Hughes","year":"2019","unstructured":"Hughes RA, Heron J, Sterne JAC, Tilling K. Accounting for missing data in statistical analyses: multiple imputation is not always the answer. Int J Epidemiol. 2019;48(4):1294\u2013304. https:\/\/doi.org\/10.1093\/ije\/dyz032.","journal-title":"Int J Epidemiol"},{"issue":"10","key":"1674_CR28","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.jclinepi.2006.01.015","volume":"59","author":"GJ van der Heijden","year":"2006","unstructured":"van der Heijden GJ, Donders AR, Stijnen T, Moons KG. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol. 2006;59(10):1102\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2006.01.015.","journal-title":"J Clin Epidemiol"},{"key":"1674_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jclinepi.2020.03.028","volume":"125","author":"M Sperrin","year":"2020","unstructured":"Sperrin M, Martin GP, Sisk R, Peek N. Missing data should be handled differently for prediction than for description or causal explanation. J Clin Epidemiol. 2020;125:183\u20137. https:\/\/doi.org\/10.1016\/j.jclinepi.2020.03.028.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1674_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/jamia\/ocaa242","volume":"28","author":"R Sisk","year":"2021","unstructured":"Sisk R, Lin L, Sperrin M, Barrett JK, Tom B, Diaz-Ordaz K, et al. Informative presence and observation in routine health data: a review of methodology for clinical risk prediction. J Am Med Inform Assoc. 2021;28(1):155\u201366. https:\/\/doi.org\/10.1093\/jamia\/ocaa242.","journal-title":"J Am Med Inform Assoc"},{"key":"1674_CR31","first-page":"197","volume":"1","author":"C Stein","year":"1956","unstructured":"Stein C. Inadmissibility of the usual estimator for the mean of a multivariate distribution. Proc Third Berkeley Symp Math Statist. 1956;1:197\u2013206.","journal-title":"Proc Third Berkeley Symp Math Statist"},{"key":"1674_CR32","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1002\/sim.8682","volume":"39","author":"J Hoogland","year":"2020","unstructured":"Hoogland J, van Barreveld M, Debray TPA, Reitsma JB, Verstraelen TE, Dijkgraaf MGW, Zwinderman AH. Handling missing predictor values when validating and applying a prediction model to new patients. Stat Med. 2020;39:3591\u2013607. https:\/\/doi.org\/10.1002\/sim.8682.","journal-title":"Stat Med"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-022-01674-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-022-01674-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-022-01674-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T09:05:03Z","timestamp":1658394303000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-022-01674-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,21]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1674"],"URL":"https:\/\/doi.org\/10.1186\/s12874-022-01674-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1716616\/v1","asserted-by":"object"}]},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,21]]},"assertion":[{"value":"3 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PBCG data were collected following IRB approval at UT Health San Antonio, Memorial Sloan Kettering Cancer Center, Mayo Clinic, University of Zurich, VA Durham, VA Caribbean\u00a0Healthcare System San Juan, P.R., VA Durham, San Raffaele Hospital, Sunnybrook Health Systems, University of California San Francisco, Hamburg University Hospital. Analyses on anonymized data for this study were approved by the Technical University of Munich Ethics Commission. Consent was waived for all data collection, which involved only record extraction of standard clinical care elements. For detailed family history collected at the Durham VA written consent was obtained by all participants as required for a local study prior to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Andrew Vickers receives royalties from the 4Kscore, a test used in prostate cancer. He owns stock options in Opko, which offers the test. All other authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}